These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2223270

  • 1. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
    Yokoyama M.
    No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
    [Abstract] [Full Text] [Related]

  • 2. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N.
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [Abstract] [Full Text] [Related]

  • 3. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA, Sherman BM, Chapler FK, VanGilder J.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors.
    Charpentier G, de Plunkett T, Jedynak P, Peillon F, Le Gentil P, Racadot J, Visot A, Derome P.
    Horm Res; 1985 Jun; 22(3):222-7. PubMed ID: 4054842
    [Abstract] [Full Text] [Related]

  • 5. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J, Page MD, Bevan JS, Richards SH, Douglas-Jones AG, Scanlon MF.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
    Dogansen SC, Selcukbiricik OS, Tanrikulu S, Yarman S.
    Pituitary; 2016 Jun; 19(3):303-10. PubMed ID: 26830552
    [Abstract] [Full Text] [Related]

  • 14. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB, Su ZP, Wu JS, Zheng WM, Zhuge QC, Zhong M.
    Pituitary; 2008 Jun; 11(1):63-70. PubMed ID: 17917811
    [Abstract] [Full Text] [Related]

  • 15. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C, Tena G, Fonseca ME, Ochoa R, Bermúdez JA, Zárate A.
    Arch Med Res; 1994 Jun; 25(1):1-3. PubMed ID: 8019107
    [Abstract] [Full Text] [Related]

  • 16. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
    Hildebrandt G, Bauer T, Stracke H, Fassbender WJ, Mueller HW, Agnoli AL, Federlin K, Roosen K.
    Zentralbl Neurochir; 1992 Jun; 53(3):123-34. PubMed ID: 1414079
    [Abstract] [Full Text] [Related]

  • 17. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M, Pagani G, Gianola D, Pagani MD, Salmoiraghi M, Ferrari L, Lancranjan I.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.